Allison Hannibal

Allison Hannibal has extensive experience in the pharmaceutical and healthcare industry. Allison currently holds the position of Head of Clinical Outsourcing and Finance at Amylyx Pharmaceuticals since September 2023. Prior to that, they served as the Executive Director of Outsourcing & Vendor Management at Mersana Therapeutics from January 2022 to September 2023. Allison also held various roles at Alkermes, starting as an Associate Director of Clinical Outsourcing and Finance in September 2012 and eventually becoming the Senior Director in January 2021. Allison worked at Boston Children's Hospital from 2010 to 2012 as part of the Clinical Trial Business Analysis team. Other notable roles include Consultant at Taligen Therapeutics, Associate Director at Endo Pharmaceuticals, Program Business Analyst at OXiGENE, and Contract Analyst at Antigenics. Their career began at Coley Pharmaceutical Group in 1998, where they served as Manager of Finance and Administration. Allison's early experience also includes roles at Genome Therapeutics Corp as a Research Scientist and Production Coordinator.

Allison Hannibal obtained their Bachelor of Science degree in Biology from Rensselaer Polytechnic Institute, studying from 1987 to 1990.